GlassScriptPhysician profile
Ramzi Samih Alami
NPI 1750469243
$10,320.44
in general payments reported to CMS, 2019-2025
13 companies · $1,485 in 2025
The $1,485 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $301 · 2023: $1,553 · 2024: $6,834 · 2025: $1,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $2,587 · Food and Beverage: $1,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $2,586.50 |
| Food and Beverage | $1,785.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,027.05 | 2023-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $373.98 | 2022-2024 | Gore Synecor Biomaterial |
| Medtronic, INC. | $228.55 | 2023-2024 | Signia |
| Davol INC. | $151.43 | 2022-2025 | Phasix Mesh |
| Ethicon US, LLC | $117.06 | 2021 | |
| Tela Bio, INC. | $108.55 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Novo Nordisk INC | $95.61 | 2023-2024 | Wegovy |
| Cumberland Pharmaceuticals, INC. | $80.21 | 2022 | |
| Heron Therapeutics, INC. | $62.85 | 2021-2022 | |
| Abbvie INC. | $22.25 | 2024 | |
| Integra Lifesciences Corporation | $19.43 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Convatec INC. | $16.95 | 2022 | |
| Intra-Sana Laboratories | $16.52 | 2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramzi Alami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.